The DOI matches its Crossref record; 27 of the 28 references it cites were found in a registry or an index.
Impact of Intensive Glycemic Control on the Incidence of Atrial Fibrillation and Associated Cardiovascular Outcomes in Patients With Type 2 Diabetes Mellitus (from the Action to Control Cardiovascular Risk in Diabetes Study)
Open accessAbstract
Atrial fibrillation (AF) is prevalent in patients with type 2 diabetes mellitus (DM) and is associated with markers of poor glycemic control; however, the impact of glycemic control on incident AF and outcomes is unknown. The aims of this study were to prospectively evaluate if intensive glycemic control in patients with DM affects incident AF and to evaluate morbidity and mortality in patients with DM and incident AF. A total of 10,082 patients with DM from the Action to Control Cardiovascular Risk in Diabetes (ACCORD) cohort were studied in a randomized, double-blind fashion. Participants were randomized to an intensive therapeutic strategy targeting a glycated hemoglobin level of <6.0% or a standard strategy targeting a glycated hemoglobin level of 7.0% to 7.9%. Incident AF occurred in 159 patients (1.58%) over the follow-up period, at a rate of 5.9 per 1,000 patient-years in the intensive-therapy group and a rate of 6.37 per 1,000 patient-years in the standard-therapy group (p = 0.52). In a multivariate model, predictors of incident AF were age, weight, diastolic blood pressure, heart rate, and heart failure history. Patients with DM and new-onset AF had a hazard ratio of 2.65 for all-cause mortality (95% confidence interval 1.8 to 3.86, p <0.0001), a hazard ratio of 2.1 for myocardial infarction (95% confidence interval 1.33 to 3.31, p = 0.0015), and a hazard ratio of 3.80 for the development of heart failure (95% confidence interval 2.48 to 5.84, p <0.0001). In conclusion, intensive glycemic control did not affect the rate of new-onset AF. Patients with DM and incident AF had an increased risk for morbidity and mortality compared with those without AF.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Unfortunately, intensive glycaemic control does not affect the rate of new-onset AF”
From 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS (2016) · cites this paper as [284]
In the citing paper
“Diabetes is a risk factor for stroke and other complications in AF.”
From 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS (2016) · cites this paper as [284]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Effects of Intensive Glucose Lowering in Type 2 Diabetes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802743 · Cited by 7,888
Benjamin, E. J. (1994) · JAMA · doi:10.1001/jama.1994.03510350050036 · Cited by 2,613
Prevalence, incidence and lifetime risk of atrial fibrillation: the Rotterdam study
Heeringa, J., van der Kuip, D. A. M., Hofman, A., Kors, J. A., van Herpen, G., Stricker, B. H. C., Stijnen, T., Lip, G. Y. H., & Witteman, J. C. M. (2006) · European Heart Journal · doi:10.1093/eurheartj/ehi825 · Cited by 1,939
Obesity and the risk of new-onset atrial fibrillation
Wang, T. J. (2004) · JAMA · doi:10.1001/jama.292.20.2471 · Cited by 1,427
Inflammation in Atrial Fibrillation
Guo, Y., Lip, G. Y. H., & Apostolakis, S. Z. (2012) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.04.063 · Cited by 868
Lazar, H. L., Chipkin, S. R., Fitzgerald, C. A., Bao, Y., Cabral, H., & Apstein, C. S. (2004) · Circulation · doi:10.1161/01.cir.0000121747.71054.79 · Cited by 713
Prineas, R. J., Crow, R. S., & BLACKBURN, H. W. (1982) · Cited by 701
Action to Control Cardiovascular Risk in Diabetes (ACCORD) Trial: Design and Methods
Buse, J. B. (2007) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2007.03.003 · Cited by 661
Huxley, R., Filion, K. B., Konety, S., & Alonso, Á. (2011) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2011.03.004 · Cited by 578
Recent advances in the molecular pathophysiology of atrial fibrillation
Wakili, R., Voigt, N., Kääb, S., Dobrev, D., & Nattel, S. (2011) · Journal of Clinical Investigation · doi:10.1172/jci46315 · Cited by 543
Hypoglycemia and cardiovascular risks
Frier, B. M., Schernthaner, G., & Heller, S. R. (2011) · Diabetes Care · doi:10.2337/dc11-s220 · Cited by 381
Movahed, M. R., Hashemzadeh, M., & Jamal, M. M. (2005) · International Journal of Cardiology · doi:10.1016/j.ijcard.2005.02.050 · Cited by 378
Diabetes mellitus, glycemic control, and risk of atrial fibrillation
Dublin, S., Glazer, N. L., Smith, N. L., Psaty, B. M., Lumley, T., Wiggins, K. L., Page, R. L., & Heckbert, S. R. (2010) · Journal of General Internal Medicine · doi:10.1007/s11606-010-1340-y · Cited by 310
Magnani, J. W., Rienstra, M., Lin, H., Sinner, M. F., Lubitz, S. A., McManus, D. D., Dupuis, J., Ellinor, P. T., & Benjamin, E. J. (2011) · Circulation · doi:10.1161/circulationaha.111.039677 · Cited by 253
Du, X., Ninomiya, T., de Galan, B., Abadir, E., Chalmers, J., Pillai, A., Woodward, M., Cooper, M., Harrap, S., Hamet, P., et al. (2009) · European Heart Journal · doi:10.1093/eurheartj/ehp055 · Cited by 239
Huxley, R., Alonso, Á., Norby, F. L., Filion, K. B., Agarwal, S. K., Loehr, L. R., Soliman, E. Z., Pankow, J. S., & Selvin, E. (2011) · Heart · doi:10.1136/heartjnl-2011-300503 · Cited by 225
Effects of Acute Insulin-Induced Hypoglycemia on Indices of Inflammation
Wright, R. J., Newby, D. E., Stirling, D., Ludlam, C. A., Macdonald, I. A., & Frier, B. M. (2010) · Diabetes Care · doi:10.2337/dc10-0013 · Cited by 208
Gerstein, H. C., Riddle, M. C., Kendall, D. M., Cohen, R. M., Goland, R., Feinglos, M. N., Kirk, J. K., Hamilton, B. P., Ismail‐Beigi, F., & Feeney, P. A. (2007) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2007.03.004 · Cited by 183
Independent Contribution of Diabetes to Increased Prevalence and Incidence of Atrial Fibrillation
Nichols, G. A., Reinier, K., & Chugh, S. S. (2009) · Diabetes Care · doi:10.2337/dc09-0939 · Cited by 181
Aksnes, T. A., Schmieder, R. E., Kjeldsen, S. E., Ghani, S., Hua, T. A., & Julius, S. (2008) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2007.10.025 · Cited by 144
AGEs‐RAGE System Mediates Atrial Structural Remodeling in the Diabetic Rat
Kato, T., Yamashita, T., SEKIGUCHI, A., Tsuneda, T., Sagara, K., Takamura, M., Kaneko, S., Aizawa, T., & Fu, L.-T. (2008) · Journal of Cardiovascular Electrophysiology · doi:10.1111/j.1540-8167.2007.01037.x · Cited by 136
Haga, K. K., McClymont, K. L., Clarke, S., Grounds, R. S., Ng, K. Y. B., Glyde, D. W., Loveless, R., Carter, G. H., & Alston, R. P. (2011) · Journal of Cardiothoracic Surgery · doi:10.1186/1749-8090-6-3 · Cited by 109
Type 2 diabetes mellitus and risk of incident atrial fibrillation in women
Schoen, T., Pradhan, A. D., Albert, C. M., & Conen, D. (2012) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.06.030 · Cited by 106
The link between diabetes and atrial fibrillation: cause or correlation?
Sun, Y., & Hu, D. (2010) · Journal of Cardiovascular Disease Research · doi:10.4103/0975-3583.59978 · Cited by 70
Relationship of Paroxysmal Atrial Tachyarrhythmias to Volume Overload
Jhanjee, R., Templeton, G. A., Sattiraju, S., Nguyen, J., Sakaguchi, S., Lü, F., Ermiş, C., Milstein, S., Heel, L. V., Lurie, K. G., et al. (2009) · Circulation Arrhythmia and Electrophysiology · doi:10.1161/circep.109.860221 · Cited by 36
Mechanism of and Therapeutic Strategy for Atrial Fibrillation Associated with Diabetes Mellitus
Lin, Y., Li, H., Lan, X., Chen, X., Zhang, A., & Li, Z. (2013) · The Scientific World JOURNAL · doi:10.1155/2013/209428 · Cited by 32
Atrial fibrillation and inflammation
Özaydın, M. (2010) · World Journal of Cardiology · doi:10.4330/wjc.v2.i8.243 · Cited by 29
Flagged first, then by citations
1 of the 28 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Heart Disease and Stroke Statistics—2017 Update: A Report From the American Heart Association
Benjamin, E. J., Blaha, M. J., Chiuve, S. E., Cushman, M., Das, S. R., Deo, R., de Ferranti, S. D., Floyd, J., Fornage, M., Gillespie, C., et al. (2017) · Circulation · doi:10.1161/cir.0000000000000485 · Cited by 12,591
Hindricks, G., Potpara, T., Dagres, N., Arbelo, E., Bax, J. J., Blomström‐Lundqvist, C., Boriani, G., Castella, M., Dan, G.-A., Dilaveris, P., et al. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehaa612 · Cited by 10,550
Heart Disease and Stroke Statistics—2020 Update: A Report From the American Heart Association
Virani, S. S., Alonso, A., Benjamin, E. J., Bittencourt, M. S., Callaway, C. W., Carson, A. P., Chamberlain, A. M., Chang, A. R., Cheng, S., Delling, F. N., et al. (2020) · Circulation · doi:10.1161/cir.0000000000000757 · Cited by 9,175
Heart Disease and Stroke Statistics—2019 Update: A Report From the American Heart Association
Benjamin, E. J., Muntner, P., Alonso, A., Bittencourt, M. S., Callaway, C. W., Carson, A. P., Chamberlain, A. M., Chang, A. R., Cheng, S., Das, S. R., et al. (2019) · Circulation · doi:10.1161/cir.0000000000000659 · Cited by 9,036
Heart disease and stroke statistics-2018 update: a report from the american heart association
Benjamin, E. J., Virani, S. S., Callaway, C. W., Chamberlain, A. M., Chang, A. R., Cheng, S., Chiuve, S. E., Cushman, M., Delling, F. N., Deo, R., et al. (2018) · Circulation · doi:10.1161/cir.0000000000000558 · Cited by 7,146
Metadata
- Authors
- Fatemi, O., Yuriditsky, E., Tsioufis, C., Tsachris, D., Morgan, T., Basile, J., Bigger, T., Cushman, W., Goff, D., Soliman, E. Z., Thomas, A., & Papademetriou, V.
- Affiliations
- MedStar Washington Hospital Center (US)
- National and Kapodistrian University of Athens (GR)
- Atrium Health Wake Forest Baptist (US)
- Medical University of South Carolina (US)
- Columbia University Irving Medical Center (US)
- University of Tennessee Health Science Center (US)
- Colorado School of Public Health (US)
- Henry Ford Health (US)
- Georgetown University (US)
- Corresponding author
- Yuriditsky, Eugene
- ORCID
- Venue
- The American Journal of Cardiology
- Publisher
- Elsevier BV
- Published
- 2014-10
- Volume
- 114
- Issue
- 8
- Pages
- 1217-1222
- ISSN
- 0002-9149 (ISSN-L)
- PMC
- PMC4291278
- OpenAlex
- W2020081546
- Cited by
- 173
- References
- 28
- Citations by year
- 2026: 8 · 2025: 10 · 2024: 12 · 2023: 16 · 2022: 18 · 2021: 21 · 2020: 20 · 2019: 15 · 2018: 17 · 2017: 14 · 2016: 13 · 2015: 9
- FWCI
- 8.22
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- The American Journal of Cardiology (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health (n01hc95184-24-0-1, n01hc95182-23-0-1)
- National Heart, Lung, and Blood Institute (N01 HC095184, N01 HC095182, Y01 HC001010, Y01 HC009035)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Atrial Fibrillation Management and Outcomes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Keywords
- atrial fibrillation, type 2 diabetes, tight glycemic control, HbA1c, cardiovascular outcomes, all-cause mortality, myocardial infarction, heart failure, atrial fibrillation risk factors, ACCORD trial
- MeSH terms
- Adult, Aged, Atrial Fibrillation, Blood Glucose, Canada, Diabetes Mellitus, Type 2, Dose-Response Relationship, Drug, Double-Blind Method, Electrocardiography, Female, Follow-Up Studies, Glycated Hemoglobin, Humans, Hypoglycemic Agents, Male, Middle Aged, Prospective Studies, Risk Factors, United States, Incidence, Prevalence, Survival Rate, Glycemic Index
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
